APA (7th ed.) Citation

S, A., & SK, A. (2021). Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications. Cardiovascular drugs and therapy, 35(3), 427. https://doi.org/10.1007/s10557-020-07070-1

Chicago Style (17th ed.) Citation

S, Agarwal, and Agarwal SK. "Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications." Cardiovascular Drugs and Therapy 35, no. 3 (2021): 427. https://doi.org/10.1007/s10557-020-07070-1.

MLA (9th ed.) Citation

S, Agarwal, and Agarwal SK. "Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications." Cardiovascular Drugs and Therapy, vol. 35, no. 3, 2021, p. 427, https://doi.org/10.1007/s10557-020-07070-1.